Han KS - Search Results

1

Gastrointestinal first-pass effect of furosemide in rats.

Kim EJ, Han KS, Lee MG. Kim EJ, et al. Among authors: han ks. J Pharm Pharmacol. 2000 Nov;52(11):1337-43. doi: 10.1211/0022357001777487. J Pharm Pharmacol. 2000. PMID: 11186241

2

Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to spontaneously hypertensive rats and DOCA-salt induced hypertensive rats.

Han KS, Lee SH, Lee MG, Kim ND. Han KS, et al. Biopharm Drug Dispos. 1993 Aug;14(6):533-48. doi: 10.1002/bdd.2510140609. Biopharm Drug Dispos. 1993. PMID: 8218971

3

Determination of a new proton pump inhibitor, YH1885, in human plasma and urine by high-performance liquid chromatography.

Han KS, Choi HC, Yoo JK, Lee JW, Lee MG. Han KS, et al. J Chromatogr B Biomed Sci Appl. 1997 Aug 29;696(2):312-6. doi: 10.1016/s0378-4347(97)00238-7. J Chromatogr B Biomed Sci Appl. 1997. PMID: 9323554

4

Stability, blood partition, and pharmacokinetics of a new reversible proton pump inhibitor, YJA-20379-1.

Kim SH, Han KS, Choi WS, Chang MS, Lee MG. Kim SH, et al. Among authors: han ks. Res Commun Mol Pathol Pharmacol. 1997 Oct;98(1):77-84. Res Commun Mol Pathol Pharmacol. 1997. PMID: 9434317

5

Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous administration to rabbits.

Han KS, Woo SJ, Koo CH, Lee MG. Han KS, et al. Res Commun Mol Pathol Pharmacol. 1998 Apr;100(1):29-34. Res Commun Mol Pathol Pharmacol. 1998. PMID: 9644716

6

Stability, blood partition, and pharmacokinetics of a new proton pump inhibitor, YJA-20379-8.

Chung SY, Han KS, Chung YK, Chang MS, Lee MG. Chung SY, et al. Among authors: han ks. Res Commun Mol Pathol Pharmacol. 1998 May;100(2):187-200. Res Commun Mol Pathol Pharmacol. 1998. PMID: 9667073

7

Determination of a chemoprotective agent, 2-(allylthio)pyrazine, in plasma, urine and tissue homogenates by high-performance liquid chromatography.

Han KS, Woo SJ, Koo CH, Lee MG. Han KS, et al. J Chromatogr B Biomed Sci Appl. 1998 Jun 12;710(1-2):239-42. doi: 10.1016/s0378-4347(98)00097-8. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9686894

8

Circadian changes in the pharmacokinetics and pharmacodynamics of azosemide in rats.

Han KS, Lee MG. Han KS, et al. J Pharm Pharmacol. 1998 Jul;50(7):767-74. doi: 10.1111/j.2042-7158.1998.tb07138.x. J Pharm Pharmacol. 1998. PMID: 9720626

9

Blood partition and protein binding of a new reversible proton pump inhibitor, YH1885.

Han KS, Kim YG, Lee JW, Lee MG. Han KS, et al. Biopharm Drug Dispos. 1998 Sep;19(6):413-5. doi: 10.1002/(sici)1099-081x(199809)19:6<413::aid-bdd128>3.0.co;2-g. Biopharm Drug Dispos. 1998. PMID: 9737823 No abstract available.

10

Pharmacokinetics of a new proton pump inhibitor, YJA-20379-8, in rats with 48-hour water deprivation.

Kim HJ, Han KS, Chung YK, Chang MS, Lee MG. Kim HJ, et al. Among authors: han ks. Res Commun Mol Pathol Pharmacol. 1998 Aug;101(2):137-46. Res Commun Mol Pathol Pharmacol. 1998. PMID: 9821210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

631 results

Search Page

Filters